Immunovant, Inc. (IMVT)

27.17 -0.58 (-2.09%) At close: 04:00PM EDT

Immunovant, Inc.

320 West 37th Street
6th Floor
New York, NY 10018
United States
(917) 580-3099
https://immunovant.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 164

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Frank M. Torti M.B.A., M.D.	Executive Chairperson of the Board	92.5k	N/A	1979
Dr. Peter Salzmann M.B.A., M.D.	CEO & Director	1.02M	N/A	1968
Ms. Eva Renee Barnett M.B.A.	Chief Financial Officer	871.07k	N/A	1981
Dr. William L. Macias M.D., Ph.D.	Chief Medical Officer	719.88k	N/A	1959
Dr. Jay S. Stout Ph.D.	Chief Technology Officer	N/A	N/A	1964
Dr. Chau Cheng M.B.A., Ph.D.	Vice President of Investor Relations	N/A	N/A	N/A
Mr. Mark S. Levine	Chief Legal Officer & Corporate Secretary	N/A	N/A	1973
Ms. Lauren Schrier M.B.A.	Vice President of Marketing	N/A	N/A	N/A
Ms. Christine Blodgett	Vice President of Human Resources	N/A	N/A	N/A
Dr. Julia G. Butchko Ph.D.	Chief Development Officer	531k	N/A	1971

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, and Graves diseases, as well as warm autoimmune hemolytic anemia. The company is headquartered in New York, New York. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.

Corporate Governance

Immunovant, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 10. The pillar scores are Audit: 7; Board: 10; Shareholder Rights: 10; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.